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Abstract
The brain-derived neurotropic factor (BDNF) Val66Met polymorphism has been associated with
abnormalities of synaptic plasticity in animal models, and abnormalities in motor cortical plasticity have also
been described in humans using transcranial direct current stimulation. No study has yet been done on
plasticity in non-motor regions, and the effect of two Met alleles (i.e. 'Met dose') is not well understood. We
studied the effect of the BDNF Val66Met polymorphism on the after-effects of transcranial direct current
stimulation and tetanic auditory stimulation in 65 subjects (23; Val66Val, 22; Val66Met and 20; Met66Met
genotypes). In the first session, motor evoked potentials (MEP) were recorded under stereotaxic guidance for
90 min after 9 min of anodal transcranial direct current stimulation (TDCS). In the second session, auditory-
evoked potentials (AEP) were recorded before and after 2 min of auditory 13 Hz tetanic stimulation. There
was a difference in MEP facilitation post-TDCS comparing Met carriers with non-Met carriers, with Met
carriers having a modest late facilitation at 30-90 min. There was no difference in responses between Val66Met
genotype and Met66Met genotype subjects. Tetanic auditory stimulation also produced late facilitation of
N1-P2 AEP at 25 min, but there was no apparent effect of genetic status. This study indicates that Met66Met
carriers behave like Val66Met carriers for TDCS-induced plasticity, and produce a late facilitation of MEPs.
Auditory cortical plasticity was not affected by the BDNF Val66Met polymorphism. This study sheds light on
the differences between auditory and motor cortical plasticity and the role of the BDNF Val66Met
polymorphism.
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Abstract
The brain-derived neurotropic factor (BDNF) Val66Met polymorphism has been associated with abnormalities of
synaptic plasticity in animal models, and abnormalities in motor cortical plasticity have also been described in
humans using transcranial direct current stimulation. No study has yet been done on plasticity in non-motor
regions, and the effect of two Met alleles (i.e. ‘Met dose’) is not well understood. We studied the effect of the
BDNF Val66Met polymorphism on the after-effects of transcranial direct current stimulation and tetanic auditory
stimulation in 65 subjects (23; Val66Val, 22; Val66Met and 20; Met66Met genotypes). In the first session, motor
evoked potentials (MEP) were recorded under stereotaxic guidance for 90min after 9min of anodal transcranial
direct current stimulation (TDCS). In the second session, auditory-evoked potentials (AEP) were recorded before
and after 2min of auditory 13 Hz tetanic stimulation. There was a difference in MEP facilitation post-TDCS
comparing Met carriers with non-Met carriers, with Met carriers having a modest late facilitation at
30–90min. There was no difference in responses between Val66Met genotype and Met66Met genotype subjects.
Tetanic auditory stimulation also produced late facilitation of N1-P2 AEP at 25min, but there was no apparent
effect of genetic status. This study indicates that Met66Met carriers behave like Val66Met carriers for
TDCS-induced plasticity, and produce a late facilitation of MEPs. Auditory cortical plasticity was not affected
by the BDNF Val66Met polymorphism. This study sheds light on the differences between auditory and motor
cortical plasticity and the role of the BDNF Val66Met polymorphism.
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Introduction
The study of human cortical plasticity has accelerated in
the last decade with multiple non-invasive neurophysio-
logical techniques developed to measure plasticity in
the motor cortex (Nitsche and Paulus, 2000; Stefan
et al., 2002; Huang et al., 2005). These approaches now
provide a real opportunity to test synaptic plasticity
as a treatment paradigm for a wide variety of central
nervous system (CNS) disorders as well as a platform
to develop and test new synaptogenic treatments
(Nathan et al., 2011; Lu et al., 2013).
The brain-derived neurotropic factor (BDNF) is a
modulator of synaptic plasticity in the form of
long-term-potentiation (LTP) and long-term-depression
(LTD) in animal studies (Figurov et al., 1996; Woo et al.,
2005). BDNF is secreted as a pro-BDNF precursor mol-
ecule and the rate of release is activity-dependent
(Lu, 2003; Lu et al., 2008). This means that increased
pre-synaptic activity increases pro-BDNF release, which
in turn allows BDNF to act on post-synaptic TrKB-
receptors to modulate synaptic efficacy (i.e. plasticity) in
an activity-dependent fashion. A common human single
nucleotide polymorphism (SNP) – the BDNF Val66Met
(rs6265) – lies on the pro-region of BDNF and reduces
activity-dependent secretion of the pro-BDNF precursor
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molecule making (−18% for Val66Met and −30% for
Met66Met) (Egan et al., 2003; Chen et al., 2006). While
the functional consequences in healthy human subjects
that have been described include reduced hippocampal
volume (Pezawas et al., 2004) and episodic memory
(Egan et al., 2003; Pezawas et al., 2004), it is incompletely
understood how the expected neurophysiological effects
translate to functional changes.
Several studies have shown an effect of the
BDNF Val66Met polymorphism on the after-effects of
theta-burst transcranial magnetic stimulation (TMS),
paired-associative stimulation and use-dependent plas-
ticity (Kleim et al., 2006; Cheeran et al., 2008) indicating
a role in human motor cortical synaptic plasticity.
However, independent groups have not been able to re-
liably reproduce the effect of the polymorphism alone
with use-dependent plasticity (McHughen and Cramer,
2013), theta-burst stimulation (Li Voti et al., 2011) and
to a degree, paired-associative stimulation (Witte et al.,
2012). For transcranial direct current stimulation
(TDCS), there has only been one retrospective study in
humans suggesting an effect of the polymorphism
(Antal et al., 2010), but this has not yet been indepen-
dently verified. The only other relevant study is a study
of TDCS in a mouse model (Fritsch et al., 2010).
The study of the uncommon Met66Met genotype in
humans is limited due to the relative rarity [frequency
of 5% in Caucasians, 20–40% in Han Chinese in Beijing
(The International HapMap Consortium, 2007)]. There
has only been one study to date of Met66Met humans:
a study of seven subjects with the Met66Met genotype
who behaved similarly to ten subjects with the
Val66Met genotype for paired-associative stimulation
and use-dependent plasticity (Cirillo et al., 2012).
The effect of the BDNF polymorphism on cortical
activity or plasticity has not been described in other
areas of cortex. There have been attempts to develop
neurophysiological techniques to probe synaptic excit-
ability and plasticity in other cortical areas: auditory
cortex (Clapp et al., 2005) and visual cortex (Cavuş
et al., 2012). Abnormalities in auditory cortical plasticity
(Mears and Spencer, 2012) and motor cortical plasticity
(Hasan et al., 2011) have been detected in schizophrenic
patients lending weight to a plasticity-based hypothesis
for schizophrenia (Lewis and Gonzalez-Burgos, 2008).
However, little is known about what underlies auditory
tetanic stimulation and whether it truly reflects LTP- or
LTD-like processes and whether it operates on similar
synaptic processes as measured by TDCS in the sensori-
motor cortex.
We proposed to study in greater detail the effect of this
polymorphism on motor cortical plasticity and auditory
cortical plasticity by recruiting a larger number of
BDNF Val66Val, Val66Met and Met66Met genotype indi-
viduals to allow a valid comparison and to examine the
effect of ‘Met load’ (i.e. the impact of being a Met-allele
homozygote). Motor cortical plasticity was assessed
using anodal TDCS and auditory cortical plasticity was
assessed using tetanic auditory stimulation. We hypo-
thesise that: BDNF polymorphisms would modulate the
effect of anodal TDCS; BDNF polymorphisms would
modulate the effect of tetanic auditory stimulation; and,
there would be a compound effect of the BDNF poly-
morphism based on animal studies.
Method
Subjects and BDNF genotype grouping
To determine the study population size needed to
demonstrate an expected effect, sample size was calcu-
lated based on studies of anodal TDCS (Antal et al.,
2010). Briefly, Antal et al. (2010) demonstrated an effect
of the BDNF genotype with 24 subjects with an effect
size of 0.6518. Based on this, a sample size of 65 subjects
would be needed to have α of 0.05 and β of 0.10.
Subjects were recruited from databases with in-
formation on the BDNF gene polymorphism; NIHR
Cambridge BioResource (CBRC), NIHR Oxford Bio-
Resource and GlaxoSmithKline Clinical Unit Cambridge
Biobank (which, at the time had about 10000, 4000 and
1500 available subjects, respectively). Three groups of
subjects were stratified according to the BDNF single
nucleotide polymorphism (SNP rs6265) (i.e. Met66Met,
Val66Met or Val66Val). Of the 65 subjects recruited
with fully evaluable data: 39 were provided by GSK,
25 by CBRC and 1 by Oxford, reflecting the nature of
accessibility to subjects and targeting requirements as
the study progressed. SNP screening for rs6265 was con-
ducted under ethically approved protocols and results
provided to a GSK database manager. Subjects were
designated a database code (independent of genetics
results) and provided in appropriate proportions to the
clinical recruiting team for screening (thus retaining geno-
type) blind. Subjects who passed screening according to
the study protocol were enrolled and randomised to ap-
propriate groups. One person in the team (not involved
in recruitment or analysis) was un-blinded such that
equal numbers of subjects were included in the groups
matched for age and gender.
Subjects were screened for eligibility to participate.
Exclusion criteria included (but was not limited to) the
following: any current history of Axis I psychiatric dis-
orders as determined by Mini-International Neuro-
psychiatric Interview (MINI); any previous disease or
current medical condition, which, as judged by the investi-
gator, could affect the interpretation of data; personal
or family history of epilepsy; positive pre-study HIV,
Hepatitis B surface antigenorpositiveHepatitisCantibody
result within three months of screening; history of alcohol
or substance abuse or dependence in the six months
prior to screening; regular use of tobacco- or nicotine-
containing products within six months prior to screening;
use of any centrally acting medication; positive urine
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drug test at screening orwhen tested at anyof the studyvis-
its; pregnant females as determined by positive urine hCG
test at screening and testing days; lactating females; and
drug dependence by the DSM-IV criteria within the last
six months as assessed by the MINI interview.
All subjects were Caucasian except one individual
who was of mixed ethnicity in the Val66Met group. The
genotypes in our sample were not in Hardy-Weinberg
Equilibrium. This was intentional, as we wanted to recruit
an equal number of subjects from each of the genotype
groups to look at gene-dose effects in a balanced design.
The mean age of the subjects was 40 yr (range 19–55 yr),
but subjects were not age-matched or gender-matched
due to the difficulties in identifying suitable numbers of
Met66Met individuals.
Seven subjects did not complete experiment one,
while one subject did not complete experiment two.
Non-completion was due to – one failed drug screen,
two were unable to enter into MRI due to claustrophobia
(and therefore withdrawn from study as they were unable
to complete all tasks), two withdrew due to illness and
three withdrew for personal reasons that they did not
provide.
All participants gave written informed consent for
participation in the study, which was approved by the
National Research Ethics Service (NRES) Committee –
East of England, UK. This study comprised part of larger
study of various behavioural, neuro-imaging, neuropsy-
chometric and neurophysiological assessments of the
BDNF polymorphism in human behaviour.
Genotyping
Genotyping was conducted by LGC Genomics (http://
lgcgenomics.com). SNPs were genotyped using the
KASP SNP genotyping system. KASP is a competitive
allele-specific PCR incorporating a FRET quencher cas-
sette (see http://www.lgcgenomics.com/kasp-genotyping-
reagents) and genotyped for BDNF Val66Met SNP via
TaqMan 50exonuclease assay (Applied Biosystems,
USA). See Supplemental Methods for more detail.
Experiment one
Transcranial magnetic stimulation
Nineteen subjects with Val66Val, nineteen subjects with
Val66Met, and twenty subjects with Met66Met genotypes
completed experiment one. Surface electromyography
(EMG) was recorded from the right first dorsal interos-
seus muscle (FDI), with Ag/AgCl electrodes using a
tendon-belly montage. EMG signals were amplified
with Digitimer D360 amplifiers (Digitimer, UK) with
1000×gain, band-pass filtered (30–1000Hz) and sampled
at 5000Hz using a CED1401 laboratory interface and
Signal software (Cambridge Electronic Design, UK).
Magnetic stimuli were delivered with a Magstim-200
magnetic stimulator (The Magstim Co., UK). A
figure-of-eight coil (diameter 80mm) was adjusted over
the optimal scalp position (‘hotspot’) to induce a motor-
evoked potential (MEP) in the right FDI with the coil han-
dle pointed postero-laterally at a 45° angle to the sagittal
plane. The position of the hotspot was registered using a
stereotaxic camera system (Brainsight, Rogue Resolutions,
UK), and a pen-mark was also marked on the scalp.
The resting motor threshold (RMT) was defined as the
lowest intensity capable of inducing at least five out of ten
MEPs of >50 μV peak-to-peak amplitude.
The motor cortical excitability was measured at rest at
120% RMT over ten trials by a coil-operating technician
who monitored coil position and ensured the distance
from the hot-spot was always <5mm and <5°. A second
technician monitored subject relaxation of surface EMG
for online rejection of trials with EMG activation.
Transcranial direct current stimulation
The experimental protocol was identical to previously
described studies in the literature (Nitsche et al., 2003).
Subjects were sat in semi-reclined chair. Subjects had
MEP recorded in two baseline blocks of twelve trials.
Anodal TDCS was then delivered at 1.0 mA intensity
for 9min using a battery-driven electrical stimulator
(DC-Stimulator-Plus, NeuroConn GmbH, Ilmenau,
Germany) using conductive-rubber electrodes placed in
2 saline-soaked sponges (5 cm×7 cm size; 35 cm2 area).
The motor cortical anodal electrode was fixed over the
representational field of the right FDIas identified by
TMS and the cathodal electrode placed contra-laterally
above the right orbit. This stimulation protocol was cho-
sen to induce after-effects lasting about 15min (Nitsche
and Paulus, 2000, 2001). After TDCS, MEP recordings
were then obtained at 1, 5, 10, 15, 20, 25, 30, 40, 50, 60,
75 and 90min.
Experiment two
Recording session of tetanic auditory stimulation
Twenty-three subjects with BDNF Val66Val polymorph-
ism, twenty-two subjects with BDNF Val66Met poly-
morphism and nineteen subjects with BDNF Met66Met
polymorphism completed experiment two.
The experimental protocol was similar to previous de-
scription in the literature (Clapp et al., 2005; Zaehle et al.,
2007). For auditory evoked potentials, 121 pure auditory
tones (50ms duration at 1000 Hz) presented binaurally
to subjects at pseudo-random inter-stimulus intervals
1800–2600ms (auditory recording block). Subjects were
requested to focus on a cross presented on a screen and
listen to the selection of tones. Two baseline recordings
were performed to confirm consistency of response and
confirm no effect of auditory recording block on sub-
sequent response. Tetanic auditory stimulation was then
delivered using the same stimuli (50ms duration 1000
Hz auditory tones) but presented at 13 Hz for 2min.
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Subjects were then given a break of 1min before another
auditory recording block (similar to baseline). Subjects
then performed a non-auditory task, which lasted
approximately 23min and then another auditory record-
ing block.
Auditory evoked potential components were identified
in the averaged data for each subject. N1 peak was deter-
mined as the most negative voltage reversal occurring at
Cz during the interval 75–150ms after stimulus onset.
The P2 peak was determined as the most positive voltage
reversal at Cz between 100–250ms after stimulus onset.
Data analysis
Experimenters (GB, PL and FS) performed the collection
and processing of individual subject data. All were
blinded to the genotype of the subjects during the
analysis.
For experiment one, peak-to-peak amplitude of MEP
was used as the primary measure of motor cortical excit-
ability. For auditory evoked potentials, 110 traces were
averaged and the N1-P2 peak-to-peak amplitude was
used as the primary measure of auditory cortical
excitability.
Statistical analysiswas performedby separate investiga-
tors (JT, SM and DW). Subjects were initially divided by
‘genotype’ (Val66Val, Val66Met, Met66Met) and repeated-
measures analysis of variance (ANOVA) was performed
using ‘genotype’ (Val66Val, Val66Met and Met66Met;
between-subject factor) and ‘time’ (Baseline, 1, 5, 10, 15,
20, 25, 30, 40, 50, 60, 75, 90min; within-subject factor) to
examine time effects (specifically change from baseline to
later time-points) and genetic effects at each individual
time-point, in particular focusing on the pairwise differ-
ence Val66Val vs. Met66Met (as this was expected to
yield the largest signal). An additional repeated-measures
ANOVA was performed for experiment one with
‘genotype’ as the factor of interest, having averaged the
post-baseline MEP into early and late ‘intervals’
(Baseline, 1–25 and 30–90min).
Three further ANOVAs were conducted to determine
which of three candidate genetic models (Met-dominant,
co-dominant and Val-dominant) fitted the data best by
assessing the magnitude of the dominance term in an
additive-dominant model. The approach was analogous
to that described by Lettre et al., as a ‘co-dominant
model with two degrees of freedom’ (Lettre et al., 2007),
with the difference that we decided the ‘best fit’ based
on the magnitude of the estimated dominance term
relative to the additive, rather than relying on the
p-value (i.e. if the dominance term divided by the
additive term was approximately 1 this corresponded to
Met-dominance, -1 corresponded to Val-dominance, and
0 to additive/linear).
All ANOVA models also included covariates to adjust
for gender and age. Statistical analysis was performed
using SAS 9.2 (SAS Inc). The threshold for statistical sign-
ificance (α) was set at p<0.05, two-sided.
Results
Baseline characteristics of subjects
Baseline characteristics of subjects in experiment one
and experiment two are described in Table 1 and Table 2,
respectively. There were no significant differences be-
tween the genetic groups.
Effect of BDNF genotype on transcranial direct
current stimulation
A repeated-measures ANOVA using the between-subject
factor ‘genotype’ and within-subject factor ‘time’ showed
no effect of ‘genotype’ (p=0.699), ‘time’ (p=0.555) or
Table 1. Baseline characteristics of subjects by genotype for experiment one with anodal transcranial direct current stimulation (anodal
TDCS). Figures provided represent mean±S.E.M. Numbers in parenthesis represents ranges. MSO represents mean stimulator output
BDNF genotype
Val66Val Val66Met Met66Met
Experiment 1 (TDCS)
Number of subjects 19 19 20
Age (years) 38.2±2.6 (19–54) 40.0±2.3 (24–54) 41.8±2.2 (20–55)
Gender (number of females) 11 females 12 females 13 females
RMT (%MSO) 51±2.7 (33–67%) 50±2.4 (35–70%) 56±3.5 (38–86%)
Baseline MEP amplitude (mV) 1.033±0.120 0.921±0.133 0.882±0.095
Educational attainments
No qualifications 1 2 1
Secondary school (CSE/ GCE/ GCSE) 3 5 5
High school (A’Levels) 4 2 2
Vocational qualifications 4 3 5
Tertiary degree 7 7 7
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‘genotype’× ‘time’ interaction (p=0.543). There were no
significant changes from baseline (all p>0.06). The
Val66Val vs. Met66Met comparison did not reach statisti-
cal significance at any time-point (all p>0.054) (See
Supplementary Figure 1). These results were supported
by the additional ANOVAs having averaged the post-
baseline MEP into two intervals, with no significant
changes from baseline (all p>0.10), or between the
Val66Val and Met66Met groups (all p>0.20).
The ANOVA fitting an additive-dominant model indi-
cated that Met-dominance was the best fitting genetic
model (see Methods). Fitting a repeated-measures
ANOVA using the between-subject factor ‘carrier’ (Met
carriers, Val66Val) and within-subject factor ‘interval’
showed a significantly increased cortical excitability
from baseline for Met carriers in the 30–90min interval
after anodal TDCS (p=0.038) (see Fig. 1), although there
was no significant difference between Met carriers and
Val66Val subjects (p>0.21).
Effect of BDNF genotype on tetanic
auditory stimulation
A repeated-measures ANOVA using the between-subject
factor ‘genotype’ and within-subject factor ‘time’ showed
no effect of ‘genotype’ (p=0.994) or ‘genotype’× ‘time’
interaction (p=0.282). There was an effect of ‘time’ (p=
0.009) with no significant changes from baseline at
1 min (p=0.159), but significant changes from baseline at
25min (p<0.0001). The Val66Val vs. Met66Met
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Fig. 1. (a) Motor-evoked potentials after 9min of anodal TDCS across each time-point for subjects grouped according to Met-carrier
status (solid line and squares represent Met-carriers, dashed lines and triangles represent non-Met-carriers). Black-filled squares
represent time-points p<0.05, while grey-filled squares represent time-points p<0.10 (uncorrected student’s t-test, compared with
baseline). (b) Motor-evoked potentials after 9min of anodal TDCS with time points grouped into early (<30min) and late
(530min). *represents p<0.05 with an uncorrected student’s t-test compared with baseline.
Table 2. Baseline characteristics of subjects by genotype for experiment two with auditory tetanic stimulation. Figures provided
represent mean±S.E.M. Numbers in parenthesis represents ranges. MSO represents mean stimulator output
BDNF genotype
Val66Val Val66Met Met66Met
Experiment 2 (AEP)
Number of subjects 23 22 19
Age (yr) 39.1±2.2 (19–54) 41.0±2.1 (24–54) 41.8±2.3 (20–55)
Gender (number of females) 14 females 16 females 16 females
Baseline N1-P2 amplitude (μV) 6.82±0.48 6.77±0.54 7.01±0.66
Educational attainments
No qualifications 1 2 1
Secondary school (CSE/ GCE/ GCSE) 4 5 5
High school (A’Levels) 5 3 2
Vocational qualifications 6 4 4
Tertiary degree 7 8 7
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comparison did not reach statistical significance at either
time-point (both p>0.72) (See Supplementary Figure 2).
The ANOVA fitting an additive-dominant model
resulted in no clear well-fitting genetic model. Met-
dominance was therefore investigated for consistency
with the TCDS analysis. A repeated-measures ANOVA
using the between-subject factor ‘carrier’ and within-
subject factor ‘time’ showed no effect of ‘carrier’
(p=0.835) or ‘carrier’× ‘time’ interaction (p=0.547). There
was an effect of ‘time’ (p=0.011). There was significant
change from baseline in N1-P2 amplitude at 25min
after tetanic auditory stimulation (p<0.0001) (see Fig. 2).
There was no evidence of a difference between the
Val66Val and Met66Met groups at either time-point
(both p>0.67).
Correlation of TDCS and tetanic auditory stimulation
There was no apparent correlation between the effect
at 25min after anodal TDCS and the effect at 25min
post-tetanic auditory stimulation when performing for
all subjects together (r=0.21, p=0.11) or just for
Met-carriers (r=0.25, p=0.12).
Discussion
Effect of anodal TDCS on Met-carriers
This study showed a late facilitation of MEPs after anodal
TDCS in Met-carriers similar to a previous retrospective
study of Val66Met genotype (Antal et al., 2010).
Another recent study of seven subjects with Met66Met
genotype used paired associative stimulation (PAS) and
showed that the Met66Met genotype behaved similarly
to Val66Met genotype for PAS (Cirillo et al., 2012); this
is similar to our study, which also shows similar
responses after TDCS for both Val66Met and Met66Met
subjects.
Our study and the previous study (Antal et al., 2010)
demonstrate the opposite direction of effect than would
be predicted by animal studies: Fritsch et al. (2010)
showed that BDNF gene knockout blocks the after-effects
of anodal TDCS on mouse cortical slices so human
Met-carriers would be expected to have less MEP facili-
tation rather than more longer-lasting facilitation
(>25min after stimulation). The most parsimonious expla-
nation for the reversal of direction of effect is that this
reflects a secondary phenomenon and is likely to be
linked to why the effect is so late after the stimulation.
Late effects of anodal TDCS
NMDA-receptor-dependent long-term-potentiation (LTP)
is thought to underlie the effects of artificially induced
plasticity such as anodal TDCS (Nitsche et al., 2003)
but classical LTP begins immediately after the
stimulation ends. Other forms of non-invasive artificially
induced plasticity also produce facilitation, which
builds up over 10min (PAS, Stefan et al., 2002) or
20min (intermittent theta-burst rTMS, Huang et al.,
2005) and the reason for this late build-up remains to be
elucidated.
The effect of the BDNF polymorphism on late MEP
facilitation after anodal TDCS hints at the role of late-
phase processes that BDNF modulates, like synaptic
scaling (Rutherford et al., 1998; Turrigiano et al.,
1998), late-LTP (Kelleher et al., 2004; Bramham and
Messaoudi, 2005) and neuronal growth (Anastasia et al.,
2013). Late LTP, in particular, provides an attractive
explanation as the BDNF-TrKB signalling system is
involved in synaptic tagging, a key step in late LTP
(Lu et al., 2008, 2011). Speculatively, anodal TDCS
would enhance the amount of pro-BDNF release but the
pro-BDNF would be then cleaved into BDNF and the pro-
domain. The BDNF molecule would activate the TrKB
signalling system for synaptic scaling, synaptic tagging
and late LTP (greatest extent in Val66Val genotype and
least in Met66Met genotype). Simultaneously, the pro-
domain induces acute neuronal pruning in Met-carriers
but not in non-Met carriers (Anastasia et al., 2013).
As our study shows that the BDNF Val66Met polymorph-
ism behaves like a dominant allele rather than an
additive allele on anodal TDCS, this favours that
neuronal pruning is an important component to the
late effect.
The results of this study therefore highlight the com-
plexity of human cortical plasticity measured by non-
invasive stimulation with effects operating at different
timescales via different molecular mechanisms.
Lack of effect of TDCS in BDNF Val66Val group
This study failed to demonstrate MEP facilitation after
anodal TDCS in Val66Val subjects: there is only a hint
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25min after 13Hz auditory tetanic stimulation with subjects
divided by carrier status. Black bar represents met-carriers and
grey bar represents non-Met-carriers. **represents time-points
p<0.01 (uncorrected student’s t-test, compared with baseline).
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of early facilitation in the Val66Val group (Fig. 1), which
is not statistically significant. This stands in contrast to a
previous study (Antal et al., 2010). This difference could
be methodological, but the protocol used is identical
with stricter quality safeguards (e.g. TMS delivered
under stereotaxic control and all patients having a struc-
tural MRI verifying the lack of any underlying structural
abnormality in the motor cortex).
The explanation favoured is that the mean age of
the subjects in this study (age range 19–55 years) is
substantially older compared with the previous retro-
spective TDCS study of BDNF (age 20–31 years,
Antal et al., 2010) and with usual TMS populations
(20–35 years reflecting the post-graduate and post-
doctoral population). Age has been shown to play a role
in paired-associative-stimulation cortical plasticity
(Müller-Dahlhaus et al., 2008). Although age was in-
cluded as a covariate in our models and did not
show any clear evidence for age-dependency (p=0.44),
age-related cortical atrophy would be expected to in-
crease the distance from the scalp TDCS electrode to the
cortex thereby reducing the potency of any stimulation.
Effect of BDNF Val66Met genotype on the effect of
tetanic auditory stimulation
Tetanic auditory stimulation generated an enhancement
of the cortically generated N1-P2 auditory evoked poten-
tial, but there was no modulation of BDNF polymorph-
ism on this enlargement, which is not what we initially
hypothesised.
There are several possible explanations: the problem
could be methodological. The older age group may be a
factor as a recent study showed that there was a lack of
effect of the BDNF polymorphism in motor plasticity in
older subjects (McHughen & Cramer 2013).
Another possible explanation is that the nature of the
stimulus provided in tetanic auditory stimulation may
be inappropriate. Cirillo et al., demonstrated that the
BDNF polymorphism did not modulate plasticity when
performing a simple motor task, but when subjects had
to perform a much more complex motor task, there was
clear modulation (Cirillo et al., 2012). Tetanic auditory
stimulation with a single featureless tone as used in this
study is analogous to ‘use-dependent plasticity in a sim-
ple task’, as the stimulation is physiological and natural-
istic but also fairly featureless. The role of BDNF may be
only evident on more complex auditory cortical activation
tasks like acoustic discrimination tasks, which also modu-
late N1-P2 auditory evoked potentials (Tremblay et al.,
2001; Atienza et al., 2002). This is unsurprising since the
effect of BDNF polymorphism is not consistent across
various motor cortical plasticity measures (rTMS, TDCS,
PAS, use-dependent plasticity) with each method provid-
ing different patterns of stimulation and different levels of
complexity.
Alternatively, it is also reasonable to propose that the
processes underlying event-related potential enlargement
after tetanic auditory stimulation do not involve the
pro-BDNF molecule and that more work will need to be
done to understand the mechanisms.
Limitations
Studying only the BDNF Val66Met polymorphism
is prone to confounds from other polymorphisms
that have an effect on synaptic plasticity or interact
with the BDNF Val66Met polymorphism [e.g. COMT
Val158Met polymorphism as described by Witte et al.
(2012) or dopamine neurotransmission genetic variation
as described by Pearson-Fuhrhop et al. (2013)], but
are non-uniformly distributed in the study population.
This is inherent in the study design, and all human
neuroplasticity studies to date are limited in this degree
and only large-scale genome-wide association studies
would be able to overcome this (Fernandez del Olmo
et al., 2010).
Our study did not fully match the three groups for gen-
der and age due to rarity of the individual with the
necessary genotypes, which could introduce additional
variability. We have accommodated for this by introdu-
cing these covariates into all statistical models.
Implications on this study in depression
and schizophrenia
While early studies suggested a role for low BDNF levels
in depression (Shimizu et al., 2003; Sen et al., 2008) and
TDCS has been shown to be a treatment modality in de-
pression (Brunoni et al., 2013a), it remains unproven if
TDCS produces this effect through BDNF. More recent
studies did not find a change in serum levels of BDNF
after TDCS (Palm et al., 2013) and another genetic study
suggests a role for serotonergic mechanisms (Brunoni
et al., 2013b). The BDNF phenomenon detected could
therefore reflect epiphonemon (Molendijk et al., 2013).
For schizophrenia, a number of recent studies have
shown abnormalities of plasticity in the motor cortex
(Hasan et al., 2011), visual cortex (Cavuş et al., 2012)
and auditory cortex (Mears and Spencer, 2012), lending
weight to the hypothesis of schizophrenia being a dis-
order of plasticity (Haracz, 1985; Lennox et al., 2012;
Steiner et al., 2013) and disconnection (Stephan et al.,
2006). Our study suggests that the abnormalities in corti-
cal plasticity measured by these measures of cortical plas-
ticity have heterogeneous root causes and abnormalities
in one measure of cortical plasticity do not necessarily
translate into abnormalities in other measures of cortical
plasticity.
Conclusion
This study highlights the role of BDNF in TDCS in
humans, and provides useful insights into the
BDNF polymorphism and late cortical plasticity 711
mechanisms of late-phase effects. It also contrasts the dif-
ferences of motor cortical plasticity as induced by TDCS
with auditory cortical plasticity induced by tetanic audi-
tory stimulation.
Supplementary material
For supplementary material accompanying this paper,
visit http://dx.doi.org/10.1017/S1461145713001636.
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